Description

NovoNorm(Repaglinide) tablets 1 mg. №30

Ingredients

Each tablet contains 1 mg of Repaglinide.

Dosage

The recommended dose is 1 mg taken orally before each main meal.

Indications

NovoNorm(Repaglinide) tablets are indicated for the treatment of type 2 diabetes mellitus.

Contraindications

Do not use NovoNorm(Repaglinide) tablets in patients with type 1 diabetes or diabetic ketoacidosis.

Directions

Take NovoNorm(Repaglinide) tablets orally before each main meal. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Studies have shown that Repaglinide, the active ingredient in NovoNorm tablets, effectively lowers blood glucose levels by stimulating insulin release from the pancreas. This mechanism of action helps control postprandial hyperglycemia in patients with type 2 diabetes.

Additional Information

It is important to monitor blood glucose levels regularly while taking NovoNorm tablets to adjust the dosage as needed. This medication should be used as part of a comprehensive treatment plan that includes diet and exercise.

Research has demonstrated the efficacy of Repaglinide in improving glycemic control and reducing HbA1c levels in patients with type 2 diabetes. Clinical trials have also shown that NovoNorm tablets have a rapid onset of action and a short duration, making it a suitable option for managing postprandial glucose spikes.